| Dr Grant Franz Oehler, DDS | |
|
6302 Monrovia St, Shawnee, KS 66216-2740 | |
| (913) 341-6767 | |
| Not Available |
| Full Name | Dr Grant Franz Oehler |
|---|---|
| Gender | Male |
| Speciality | Dentist - General Practice |
| Location | 6302 Monrovia St, Shawnee, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063141521 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 61917 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Grant Franz Oehler, DDS 6302 Monrovia St, Shawnee, KS 66216-2740 Ph: () - | Dr Grant Franz Oehler, DDS 6302 Monrovia St, Shawnee, KS 66216-2740 Ph: (913) 341-6767 |
News Archive
A major national study led by experts from Bristol and Nottingham has found that oral antibiotics are just as effective as intravenous antibiotics in killing a common germ that causes dangerous complications in cystic fibrosis (CF) patients.
Although U.S. food aid funding has increased by 53 percent over the last two years, a Government Accountability Office report on Wednesday said that during the same time period, the "amount of food delivered to address emergencies abroad fell 5 percent," the Washington Independent reports.
Roll Call on Wednesday examined how health care is "quickly becoming a cornerstone" of 2008 presidential candidates' domestic proposals and how "health industry groups and their lobbyists already are trying to make sure candidates in both parties keep their interests in mind along the campaign trail."
Maine Gov. Paul LePage (R) told an enthusiastic crowd at the Heritage Foundation on Monday that his Republican administration thinks "taking off the shackles" from insurers is the way to keep healthcare costs low for rural residents.
Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced the presentation of interim results from the ongoing Phase 1 trial evaluating CAL-101, an oral delta-selective PI3K inhibitor, demonstrating promising clinical responses in patients with relapsed or refractory chronic lymphocytic leukemia (CLL).
› Verified 9 days ago
Dallan Greenhalgh, DDS Dentist Medicare: Medicare Enrolled Practice Location: 6302 Monrovia St, Shawnee, KS 66216 Phone: 913-631-2400 Fax: 913-631-0545 | |
Dr. Russell Conwell Wismer, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 6301 Pflumm Rd, Shawnee, KS 66216 Phone: 913-268-7770 | |
Mansoor Safder, DDS Dentist Medicare: Medicare Enrolled Practice Location: 15834 Shawnee Mission Pkwy, Shawnee, KS 66217 Phone: 913-631-0866 | |
Beverly Moon, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 5550 Hedge Lane Ter, Shawnee, KS 66226 Phone: 913-422-6699 | |
Todd C. Burris, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 7070 Renner Rd, Suite 202, Shawnee, KS 66217 Phone: 913-268-0888 Fax: 913-268-3752 | |
David Greenhalgh, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 6345 Long St, Shawnee, KS 66216 Phone: 913-631-2400 Fax: 913-631-0545 |